Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Ph+ ALL and CML Blast Crisis
NCT00006092Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Aug 2000
- Primary completion
- Mar 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of arsenic trioxide in acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), sponsored by Moffitt Cancer Center. Started Aug 2000; status: terminated.
02
Drugs
arsenic trioxide
03
Conditions
acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00006092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006092.